Shares of UK Oil & Gas (LON: UKOG) are rising on Monday following news that it has completed a planned two-week production facility upgrade at its 85.63% owned Horse Hill oil field. Upgrade works at the oil field included modifications to prep

Shares of AIM-quoted Alba Mineral Resources (LON: ALBA) are rallying on Monday on news that it has obtained an additional exclusive mineral exploration licence. The addit

Asana Inc (NYSE: ASAN) stock has risen 53.7% over the past month as company insiders led by its CEO Dustin Moskovitz continue accumulating shares in the firm. According to a credible report, Dustin Moskovitz bought an additional 750,000 shares of

Corvus Pharmaceuticals Inc (NASDAQ: CRVS) stock soared 82.3% despite a lack of fundamental releases from the company today. However, the markets may be reacting to the clinical-stage company’s participation in the H.C. Wainwright Annual Global Inv

Shares of OILEX LTD. (LON: OEX) surged 45% after announcing that it was moving ahead with plans to return the Cambay field in India to production after completing the project’s 100% acquisition. Oilex acquired the 55% stake owned by the Gujarat St

Shares of IQ-AI Ltd (LON: IQAI) surged 5.84% after reporting that sales and licensing deals of its imaging technology developed by its subsidiary, imaging Biometric had recovered following the pandemic-induced slump. The company reported a surge i

Shares of Thor Mining Plc (LON: THR) rallied 16.9% higher after kicking off the environmentally friendly drilling campaign at its Kapunda Copper project in Southern Australia. MineEx CRC is leading the drilling programme and will utilise an innova

Shares of Helbiz Inc (NASDAQ: HLBZ) have surged on Friday after the announcement of an agreement between Helbiz Media, the company’s new streaming entertainment service, and FOX Networks Group. The agreement is for the broadcast of the Italian Ser

Video game firm Take-Two Interactive shares are down premarket on Friday after its shares were downgraded by BMO Capital. BMO Capital analyst, Gerrick Johnson, downgraded

Protagonist Therapeutics (NASDAQ: NASDAQ: PTGX) shares have plunged premarket on news that the US Food and Drug Administration (FDA) has put a clinical hold on Protagonist's clinical studies for rusfertide. A clinical hold is issued by the FDA "to

UK-based oil and gas firm Hurricane Energy's (LON: HUR) share price is rallying on Friday after it provided an operational and financial update. The AIM-listed company said that as it previously noted, following the annual shutdown, production rat

Shares of investing company Vela Technologies (LON: VELA) are rising on Friday after it noted the announcement of a partnership between Sprintex and Aeristech Limited.  I

The shares of AIM-quoted Oriole Resources (LON: ORR) declined on Friday after reporting the latest drill results from its Phase 1 reverse circulation (RC) drilling programme at the Fare prospect at the Senala projec

Shares of electric vehicle firm Lucid Group (NASDAQ: LCID) are climbing on Thursday after the company revealed it has received an official EPA rating of 520 miles of range.

Cameco's (NYSE: CCJ) shares are sliding on Thursday despite news that the company has entered a non-binding and non-exclusive Memorandum of Understanding with X-energy. T

Great Western Bancorp (NYSE: GWS) shares are rallying premarket on news that it will merge with First Interstate BancSystem (NASDAQ: FIBK), the parent company of First Interstate Bank.

Xpeng Inc - ADR (NYSE: XPEV) shares barely moved during premarket trading despite launching its new P5 sedan, the first-ever consumer-targeted car with inbuilt lidar capabilities.

Shares of AFC Energy plc (LON: AFC) barely moved after signing a hydrogen fuel cell supply and collaboration agreement with Urban-Air Port.   Urban-Air Port designs, develops a

Shares of IronNet Inc (NYSE: IRNT) were up as high as 57.11% during premarket trading as Redditors pushed the cybersecurity firm’s share price higher in a renewed surge. Howeve

Leap Therapeutics (NASDAQ: LPTX) shares are surging premarket after the company announced the presentation of updated positive data from the first-line cohort of the DisTinGuish study. The study is a Phase 2a clinical trial evaluating Leap's anti-